|
|
|
Insider
Information: |
Browne L Daniel |
Relationship: |
CEO and President, Dir... |
City: |
Newark |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
1 |
|
Direct
Shares |
152,193 |
|
Indirect Shares
|
409 |
|
|
Direct
Value |
$441,360 |
|
|
Indirect Value
|
$1,186 |
|
|
Total
Shares |
152,602 |
|
|
Total
Value |
$442,546 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Revance Therapeutics, Inc. |
RVNC |
CEO and President, Dir... |
2019-06-28 |
152,193 |
2019-06-28 |
409 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
44 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 2
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
RVNC |
Revance Therapeutics, Inc... |
CEO and President |
|
2017-01-25 |
4 |
AS |
$19.78 |
$237,398 |
D/D |
(12,000) |
184,627 |
0 |
- |
|
RVNC |
Revance Therapeutics, Inc... |
CEO and President |
|
2017-05-22 |
4 |
AS |
$20.20 |
$248,159 |
D/D |
(12,287) |
183,932 |
0 |
- |
|
RVNC |
Revance Therapeutics, Inc... |
CEO and President |
|
2017-05-24 |
4 |
AS |
$20.35 |
$401,091 |
D/D |
(19,713) |
164,219 |
0 |
- |
|
RVNC |
Revance Therapeutics, Inc... |
CEO and President |
|
2017-02-22 |
4 |
AS |
$20.56 |
$227,050 |
D/D |
(11,037) |
199,390 |
0 |
- |
|
RVNC |
Revance Therapeutics, Inc... |
CEO and President |
|
2016-12-28 |
4 |
AS |
$20.94 |
$251,250 |
D/D |
(12,000) |
195,627 |
0 |
- |
|
RVNC |
Revance Therapeutics, Inc... |
CEO and President |
|
2017-08-23 |
4 |
AS |
$22.76 |
$519,031 |
D/D |
(22,800) |
156,050 |
0 |
- |
|
RVNC |
Revance Therapeutics, Inc... |
CEO and President |
|
2017-12-29 |
4 |
A |
$22.99 |
$2,920 |
D/D |
127 |
133,315 |
0 |
- |
|
RVNC |
Revance Therapeutics, Inc... |
CEO and President |
|
2018-06-29 |
4 |
A |
$23.33 |
$15,586 |
D/D |
668 |
142,543 |
0 |
- |
|
RVNC |
Revance Therapeutics, Inc... |
CEO and President |
|
2017-09-20 |
4 |
AS |
$23.58 |
$179,185 |
D/D |
(7,600) |
148,450 |
0 |
- |
|
RVNC |
Revance Therapeutics, Inc... |
CEO and President |
|
2017-11-22 |
4 |
AS |
$24.94 |
$189,570 |
D/D |
(7,600) |
133,188 |
0 |
- |
|
RVNC |
Revance Therapeutics, Inc... |
CEO and President |
|
2015-05-19 |
4 |
D |
$25.94 |
$311,929 |
D/D |
(12,025) |
205,101 |
0 |
- |
|
RVNC |
Revance Therapeutics, Inc... |
CEO and President |
|
2017-10-18 |
4 |
AS |
$26.16 |
$200,405 |
D/D |
(7,662) |
140,788 |
0 |
- |
|
RVNC |
Revance Therapeutics, Inc... |
CEO and President |
|
2015-12-31 |
4 |
A |
$27.00 |
$7,074 |
D/D |
262 |
218,677 |
0 |
- |
|
RVNC |
Revance Therapeutics, Inc... |
CEO and President |
|
2018-03-07 |
4 |
AS |
$31.43 |
$857,505 |
D/D |
(27,283) |
131,208 |
0 |
- |
|
RVNC |
Revance Therapeutics, Inc... |
CEO and President |
|
2018-03-16 |
4 |
AS |
$31.43 |
$171,348 |
D/D |
(5,452) |
141,875 |
0 |
- |
|
RVNC |
Revance Therapeutics, Inc... |
CEO and President |
|
2018-03-15 |
4 |
D |
$31.65 |
$91,184 |
D/D |
(2,881) |
127,327 |
0 |
- |
|
RVNC |
Revance Therapeutics, Inc... |
CEO and President |
|
2018-02-15 |
4 |
D |
$31.75 |
$97,600 |
D/D |
(3,074) |
158,491 |
0 |
- |
|
RVNC |
Revance Therapeutics, Inc... |
CEO and President |
|
2014-05-19 |
4 |
A |
$32.22 |
$3,093,120 |
D/D |
96,000 |
166,626 |
0 |
- |
|
RVNC |
Revance Therapeutics, Inc... |
CEO and President |
|
2018-03-15 |
4 |
AS |
$32.80 |
$32,800 |
D/D |
(1,000) |
130,208 |
0 |
- |
|
44 Records found
|
|
Page 2 of 2 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|